Consistent with its known role as an endocrine disruptor, two of the three top enriched pathways among the 73 genes were involved in glucocorticoid receptor signaling (p-value = 1.21×10−22) and estrogen-dependent breast cancer signaling (p-value = 9.13×10−14). This evidence concerns the gene NR3C1 and breast cancer.